These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21440359)

  • 21. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichomonas vaginalis and trichomoniasis in the Republic of Korea.
    Ryu JS; Min DY
    Korean J Parasitol; 2006 Jun; 44(2):101-16. PubMed ID: 16809958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
    Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
    Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nimorazole compared with metronidazole in the treatment of vaginal trichomoniasis.
    Tinkler AE
    Practitioner; 1974 Jan; 212(267):115-9. PubMed ID: 4591199
    [No Abstract]   [Full Text] [Related]  

  • 25. Trichomonas vaginalis infections are rare among young patients attending an STI clinic in Sweden.
    Pellrud H; Golparian D; Nilsson CS; Falk M; Fredlund H; Unemo M
    Acta Derm Venereol; 2015 Mar; 95(3):343-4. PubMed ID: 25137630
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
    Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy.
    Lewis DA; Habgood L; White R; Barker KF; Murphy SM
    Int J STD AIDS; 1997 Dec; 8(12):780-4. PubMed ID: 9433954
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular typing of the actin gene of Trichomonas vaginalis isolates by PCR-RFLP in Iran.
    Momeni Z; Sadraei J; Kazemi B; Dalimi A
    Exp Parasitol; 2015 Dec; 159():259-63. PubMed ID: 26542260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of SQ109 on Trichomonas vaginalis.
    de Souza TG; Granado R; Benaim G; de Souza W; Benchimol M
    Exp Parasitol; 2023 Jul; 250():108549. PubMed ID: 37196704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trichomonas vaginalis: random amplified polymorphic DNA analysis of isolates from symptomatic and asymptomatic women in India.
    Kaul P; Gupta I; Sehgal R; Malla N
    Parasitol Int; 2004 Sep; 53(3):255-62. PubMed ID: 15468533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Trichomoniasis].
    Yasuda J
    Nihon Rinsho; 2009 Jan; 67(1):162-6. PubMed ID: 19177767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Virulence of Trichomonas vaginalis strains in relation to clinical forms of Trichomonas vaginitis].
    Małyszko E; Januszko T; Smorczewska-Czupryńska B; Ustymowicz-Farbiszewska J
    Wiad Parazytol; 1991; 37(2):219-23. PubMed ID: 1822038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of Go 10213 and some nitroimidazoles against Trichomonas vaginalis and T. Foetus in mice infected subcutaneously.
    Ray DK; Chatterjee DK; Tendulkar JS
    Ann Trop Med Parasitol; 1982 Apr; 76(2):175-8. PubMed ID: 6979983
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
    Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
    Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mind the gap: bridging the divide between clinical and molecular studies of the trichomonads.
    Lyons EJ; Carlton JM
    Trends Parasitol; 2004 May; 20(5):204-7. PubMed ID: 15105016
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistant trichomoniasis: successful treatment with combination therapy.
    Nyirjesy P; Gilbert J; Mulcahy LJ
    Sex Transm Dis; 2011 Oct; 38(10):962-3. PubMed ID: 21934573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological variability in clinical isolates of Trichomonas vaginalis.
    Gómez-Barrio A; Nogal-Ruiz JJ; Montero-Pereira D; Rodríguez-Gallego E; Romero-Fernandez E; Escario JA
    Mem Inst Oswaldo Cruz; 2002 Sep; 97(6):893-6. PubMed ID: 12386717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trichomoniasis.
    Schwebke JR; Burgess D
    Clin Microbiol Rev; 2004 Oct; 17(4):794-803, table of contents. PubMed ID: 15489349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of 120 kDa Pyruvate:Ferredoxin Oxidoreductase on Pathogenicity of Trichomonas vaginalis.
    Song HO
    Korean J Parasitol; 2016 Feb; 54(1):71-4. PubMed ID: 26951982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.